Kura Oncology (KURA) Net Cash Flow (2010 - 2026)
Kura Oncology (KURA) reported Net Cash Flow of -$110.0 million for Q1 2026, up 36.48% year-over-year from -$80.6 million in Q1 2025, and down 304.45% on a QoQ basis from $53.8 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Net Cash Flow data on file, last reported at -$110.0 million in Q1 2026.
- Quarterly Net Cash Flow rose 36.48% year-over-year to -$110.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 224.82% YoY) and the FY2025 annual result came in at -$75.4 million, down 140.27% from the prior year.
- Net Cash Flow fell to -$110.0 million in Q1 2026 per KURA's latest filing, from $53.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $175.0 million in Q4 2024 and bottomed at -$173.2 million in Q1 2025.
- The 5-year median for Net Cash Flow is $4.2 million (2024), against an average of -$8.6 million.
- The widest annual swing landed in 2022, when Net Cash Flow soared 24627.27%; it then sank 4235.46% in 2025.
- Tracing KURA's Net Cash Flow over 5 years: stood at -$39.1 million in 2022, then soared by 121.92% to $8.6 million in 2023, then surged by 1939.89% to $175.0 million in 2024, then plunged by 69.25% to $53.8 million in 2025, then plunged by 304.45% to -$110.0 million in 2026.
- Per Business Quant, the three latest KURA Net Cash Flow figures stand at -$110.0 million (Q1 2026), $53.8 million (Q4 2025), and $13.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -110.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110.02 Mn |
| Mar 31, 2026 | -110.02 Mn |
| Dec 31, 2025 | 53.81 Mn |
| Dec 31, 2025 | 53.81 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Jun 30, 2025 | 30.68 Mn |
| Jun 30, 2025 | 30.68 Mn |
| Mar 31, 2025 | -173.19 Mn |
| Mar 31, 2025 | -173.19 Mn |
| Dec 31, 2024 | 174.98 Mn |
| Dec 31, 2024 | 174.98 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 3.68 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 8.58 Mn |
| Dec 31, 2023 | 8.58 Mn |
| Sep 30, 2023 | -20.38 Mn |
| Sep 30, 2023 | -20.38 Mn |
| Jun 30, 2023 | -71.94 Mn |
| Jun 30, 2023 | -71.94 Mn |
| Mar 31, 2023 | -24.74 Mn |
| Mar 31, 2023 | -24.74 Mn |
| Dec 31, 2022 | -39.14 Mn |
| Dec 31, 2022 | -39.14 Mn |
| Sep 30, 2022 | 51.68 Mn |
| Sep 30, 2022 | 51.68 Mn |
| Jun 30, 2022 | 5.43 Mn |
| Jun 30, 2022 | 5.43 Mn |
| Mar 31, 2022 | -56.84 Mn |
| Mar 31, 2022 | -56.84 Mn |
| Dec 31, 2021 | 51.49 Mn |
| Dec 31, 2021 | 51.49 Mn |
| Sep 30, 2021 | 209,000.00 |
| Sep 30, 2021 | 209,000.00 |
| Jun 30, 2021 | -71.86 Mn |
| Jun 30, 2021 | -71.86 Mn |
| Mar 31, 2021 | -214.66 Mn |
| Mar 31, 2021 | -214.66 Mn |
| Dec 31, 2020 | 248.54 Mn |
| Dec 31, 2020 | 248.54 Mn |
| Sep 30, 2020 | -57.80 Mn |
| Sep 30, 2020 | -57.80 Mn |
| Jun 30, 2020 | 100.95 Mn |
| Jun 30, 2020 | 100.95 Mn |
| Mar 31, 2020 | 7.89 Mn |
| Mar 31, 2020 | 7.89 Mn |
| Dec 31, 2019 | -28.61 Mn |
| Dec 31, 2019 | -28.61 Mn |
| Sep 30, 2019 | -67.34 Mn |
| Sep 30, 2019 | -67.34 Mn |
| Jun 30, 2019 | 104.30 Mn |
| Jun 30, 2019 | 104.30 Mn |
| Mar 31, 2019 | 1.66 Mn |
| Mar 31, 2019 | 1.66 Mn |
| Dec 31, 2018 | -4.45 Mn |
| Dec 31, 2018 | -4.45 Mn |
| Sep 30, 2018 | 2.91 Mn |
| Sep 30, 2018 | 2.91 Mn |
| Jun 30, 2018 | -8.86 Mn |
| Jun 30, 2018 | -8.86 Mn |
| Mar 31, 2018 | 15.09 Mn |
| Mar 31, 2018 | 15.09 Mn |
| Dec 31, 2017 | -11.90 Mn |
| Dec 31, 2017 | -11.90 Mn |
| Sep 30, 2017 | 11.18 Mn |
| Sep 30, 2017 | 11.18 Mn |
| Jun 30, 2017 | 1.51 Mn |
| Jun 30, 2017 | 1.51 Mn |
| Mar 31, 2017 | 917,000.00 |
| Mar 31, 2017 | 917,000.00 |
| Dec 31, 2016 | 2.94 Mn |
| Dec 31, 2016 | 2.94 Mn |
| Sep 30, 2016 | -5.33 Mn |
| Sep 30, 2016 | -5.33 Mn |
| Jun 30, 2016 | -11.67 Mn |
| Jun 30, 2016 | -11.67 Mn |
| Mar 31, 2016 | 883,000.00 |
| Mar 31, 2016 | 883,000.00 |
| Dec 31, 2015 | 4.23 Mn |
| Dec 31, 2015 | 4.23 Mn |
| Sep 30, 2015 | -8.57 Mn |
| Sep 30, 2015 | -8.57 Mn |
| Jun 30, 2015 | -33.78 Mn |
| Jun 30, 2015 | -33.78 Mn |
| Mar 31, 2015 | 52.45 Mn |
| Mar 31, 2015 | 52.45 Mn |
| Dec 31, 2014 | 1.12 Mn |
| Dec 31, 2014 | 1.12 Mn |
| Sep 30, 2014 | 82,000.00 |
| Sep 30, 2014 | 82,000.00 |
| Jun 30, 2014 | -1,250.00 |
| Jun 30, 2014 | -1,250.00 |
| Mar 31, 2014 | -400.00 |
| Mar 31, 2014 | -400.00 |
| Dec 31, 2013 | -4,012.00 |
| Dec 31, 2013 | -4,012.00 |
| Sep 30, 2013 | -8,125.00 |
| Sep 30, 2013 | -8,125.00 |
| Jun 30, 2013 | 15,804.00 |
| Jun 30, 2013 | 15,804.00 |
| Mar 31, 2013 | -1,901.00 |
| Mar 31, 2013 | -1,901.00 |
| Dec 31, 2012 | -784.00 |
| Dec 31, 2012 | -784.00 |
| Sep 30, 2012 | -3,895.00 |
| Sep 30, 2012 | -3,895.00 |
| Jun 30, 2012 | -14,262.00 |
| Jun 30, 2012 | -14,262.00 |
| Mar 31, 2012 | 19,523.00 |
| Mar 31, 2012 | 19,523.00 |
| Dec 31, 2011 | -1,935.00 |
| Dec 31, 2011 | -1,935.00 |
| Sep 30, 2011 | -3,100.00 |
| Sep 30, 2011 | -3,100.00 |
| Jun 30, 2011 | -15,379.00 |
| Jun 30, 2011 | -15,379.00 |
| Mar 31, 2011 | -2,264.00 |
| Mar 31, 2011 | -2,264.00 |
| Dec 31, 2010 | 24,644.00 |
| Dec 31, 2010 | 24,644.00 |
| Sep 30, 2010 | -3,506.00 |
| Sep 30, 2010 | -3,506.00 |